West Paces Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-40
| Closed | -$4.76K | – | 572 |
|
|
2024
Q3 | $4.76K | Sell |
40
-300
| -88% | -$35.7K | ﹤0.01% | 387 |
|
|
2024
Q2 | $48.5K | Sell |
340
-40
| -11% | -$5.71K | 0.01% | 220 |
|
|
2024
Q1 | $48.8K | Hold |
380
| – | – | 0.01% | 233 |
|
|
2023
Q4 | $39.3K | Buy |
380
+80
| +27% | +$8.28K | 0.01% | 246 |
|
|
2023
Q3 | $27.3K | Hold |
300
| – | – | 0.01% | 270 |
|
|
2023
Q2 | $24.3K | Hold |
300
| – | – | 0.01% | 288 |
|
|
2023
Q1 | $23.9K | Hold |
300
| – | – | 0.01% | 288 |
|
|
2022
Q4 | $20.3K | Hold |
300
| – | – | 0.01% | 290 |
|
|
2022
Q3 | $14.9K | Buy |
+300
| New | +$14.9K | 0.01% | 304 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 519 |
|
|
2017
Q1 | – | Sell |
-500
| Closed | -$8.97K | – | 530 |
|
|
2016
Q4 | $8.97K | Buy |
+500
| New | +$8.97K | 0.01% | 348 |
|